Download PDF
Share
Icahn School of Medicine at Mount Sinai, Feinstein IBD Center
Fecal Microbiota Transplant for C Difficile Colitis
Exploring the mechanism and clinical utility of FMT in Clostridium difficile infection and Inflammatory Bowel Disease.
Ari Grinspan, MD, is an Assistant Professor in the Department of Medicine, Division of Gastroenterology and the Director of the GI Microbial Therapeutics. He received his medical degree from the Albert Einstein College of Medicine in New York and completed his Internal Medicine training at New York-Presbyterian Hospital. He completed his fellowship in Gastroenterology at Mount Sinai Medical Center, where he remains as full-time faculty. Dr. Grinspan pioneered the Fecal Microbiota Transplant (FMT) program to treat recurrent and refractory Clostridium difficile infection at Mount Sinai, which has developed into a referral center for the tri-state area. His research focuses on exploring the mechanism and clinical utility of FMT in Clostridium difficile infection and Inflammatory Bowel Disease.
Mount Sinai Hospital
2011 - 2014
Fellowship, Gastroenterology
New York Presbyterian Hospital-Weill Cornell
2008 - 2011
Residency, Internal Medicine
Albert Einstein College of Medicine
2004 - 2008
MD